Trial Profile
A study investigating the association between cerebellar plaques and quantification of florbetaben amyloid PET scan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Apr 2019
Price :
$35
*
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 27 Mar 2019 According to a Life Molecular Imaging, Piramal imaging changed its name to Life Molecular Imaging.
- 14 Oct 2015 New trial record